The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis

References

• SuLHChenTHAssociation of androgenetic alopecia with smoking and its prevalence among Asian men: a community-based surveyArch Dermatol2007143111401140618025364
   PubMedGoogle Scholar
• HanSHByunJWLeeWSQuality of life assessment in male patients with androgenetic alopecia: result of a prospective, multicenter studyAnn Dermatol201224331131822879715
   PubMed Web of Science ®Google Scholar
• WolffHFischerTWBlume-PeytaviUThe diagnosis and treatment of hair and scalp diseasesDtsch Arztebl Int20161132137738627504707
   PubMed Web of Science ®Google Scholar
• WhitingDAMale pattern hair loss: current understandingInt J Dermatol19983785615669731996
   PubMed Web of Science ®Google Scholar
• InuiSItamiSMolecular basis of androgenetic alopecia: from androgen to paracrine mediators through dermal papillaJ Dermatol Sci20116111621167691
   PubMed Web of Science ®Google Scholar
• SatoATakedaAEvaluation of efficacy and safety of finasteride 1 Mg in 3177 Japanese men with androgenetic alopeciaJ Dermatol2012391273221980923
   PubMed Web of Science ®Google Scholar
• MysoreVShashikumarBMGuidelines on the use of finasteride in androgenetic alopeciaIndian J Dermatol Venereol Leprol201682212813426924401
   PubMed Web of Science ®Google Scholar
• PriceVHMenefeeESanchezMKaufmanKDChanges in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year resultsJ Am Acad Dermatol2006551717416781295
   PubMed Web of Science ®Google Scholar
• SinclairRMale pattern androgenetic alopeciaBMJ199831771628658699748188
   PubMed Web of Science ®Google Scholar
• BramsonHNHermannDBatchelorKWLeeFWJamesMKFryeSVUnique preclinical characteristics of GG745, a potent dual inhibitor of 5ARJ Pharmacol Exp Ther19972823149615029316864
   PubMed Web of Science ®Google Scholar
• MoherDLiberatiATetzlaffJAltmanDGPRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementAnn Intern Med2009151426426919622511
   PubMed Web of Science ®Google Scholar
• JadadARRandomised Controlled TrialsLondonBMJ Publishing Group1998
   Google Scholar
• HigginsJPGreenSCochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 [Internet]The Cochrane Collaboration2011 [uptated March 2011; cited May 10, 2017[. Available from: www.cochrane-handbook.orgAccessed Aug 30, 2018
   Google Scholar
• DersimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
   PubMedGoogle Scholar
• Gubelin HarchaWBarboza MartínezJTsaiTFA randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopeciaJ Am Acad Dermatol201470348949824411083
   PubMed Web of Science ®Google Scholar
• OlsenEAHordinskyMWhitingDThe importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasterideJ Am Acad Dermatol20065561014102317110217
   PubMed Web of Science ®Google Scholar
• ShanshanwalSJDhuratRSSuperiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: a randomized controlled open-label, evaluator-blinded studyIndian J Dermatol Venereol Leprol2017831475427549867
   PubMed Web of Science ®Google Scholar
• TangPHChiaHPCheongLLKohDA community study of male androgenetic alopecia in Bishan, SingaporeSingapore Med J200041520220511063167
   PubMedGoogle Scholar
• YazdabadiAMageeJHarrisonSSinclairRThe Ludwig pattern of androgenetic alopecia is due to a hierarchy of androgen sensitivity within follicular units that leads to selective miniaturization and a reduction in the number of terminal hairs per follicular unitBr J Dermatol200815961300130218795932
   PubMed Web of Science ®Google Scholar
• CashTFPriceVHSavinRCPsychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjectsJ Am Acad Dermatol19932945685758408792
   PubMed Web of Science ®Google Scholar
• CashTFThe psychological effects of androgenetic alopecia in menJ Am Acad Dermatol19922669269311607410
   PubMed Web of Science ®Google Scholar
• TraishAMNegative impact of testosterone deficiency and 5α-reductase inhibitors therapy on metabolic and sexual function in menAdv Exp Med Biol2017104347352629224108
   PubMed Web of Science ®Google Scholar
• ClarkRVHermannDJCunninghamGRWilsonTHMorrillBBHobbsSMarked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitorJ Clin Endocrinol Metab20048952179218415126539
   PubMed Web of Science ®Google Scholar
• PremanandAReena RajkumariBAndrogen modulation of Wnt/β-catenin signaling in androgenetic alopeciaArch Dermatol Res2018310539139929549490
   PubMed Web of Science ®Google Scholar
• RoehrbornCGBoylePNickelJCHoefnerKAndrioleGARIA3001 ARIA3002 and ARIA3003 Study InvestigatorsEfficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasiaUrology200260343444112350480
   PubMed Web of Science ®Google Scholar
• DallobALSadickNSUngerWThe effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotes-tosterone concentrations in patients with male pattern baldnessJ Clin Endocrinol Metab19947937037068077349
   PubMed Web of Science ®Google Scholar
• DebruyneFBarkinJvan ErpsPEfficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasiaEur Urol200446448849515363566
   PubMed Web of Science ®Google Scholar
• AndrioleGLBostwickDGBrawleyOWEffect of dutasteride on the risk of prostate cancerN Engl J Med2010362131192120220357281
   PubMed Web of Science ®Google Scholar
• HaddadAJabbourMBulbulMPhosphodiesterase type 5 inhibitors for treating erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia: a comprehensive reviewArab J Urol201513315516126413339
   PubMed Web of Science ®Google Scholar
• PinskyMRGurSTraceyAJHarbinAHellstromWJThe effects of chronic 5-alpha-reductase inhibitor (dutasteride) treatment on rat erectile functionJ Sex Med20118113066307421834872
   PubMed Web of Science ®Google Scholar
• KaufmanKDFinasteride Male Pattern Hair Loss Study GroupLong-term (5-year) multinational experience with finasteride 1 Mg in the treatment of men with androgenetic alopeciaEur J Dermatol2002121384911809594
   PubMed Web of Science ®Google Scholar